- Home
- Publications
- Publication Search
- Publication Details
Title
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
Authors
Keywords
-
Journal
Frontiers in Chemistry
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-24
DOI
10.3389/fchem.2018.00178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology
- (2018) Finn Peters et al. ACTA NEUROPATHOLOGICA
- Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer’s Disease
- (2018) Iryna Voytyuk et al. BIOLOGICAL PSYCHIATRY
- BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
- (2018) Xiangyou Hu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis
- (2017) Sara Azimi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-Substituted-thio- N -(4-substituted-thiazol/1 H -imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies
- (2017) Gang Yan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease
- (2017) Federica Prati et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- BACE inhibitor bust in Alzheimer trial
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
- (2017) Riqiang Yan Frontiers in Molecular Neuroscience
- Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors
- (2016) Priti Jain et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors
- (2016) Priti Jain et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities
- (2016) Quang De Tran et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of furo[2,3- d ][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors
- (2016) Yong-Jin Wu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
- (2016) Susanna Eketjäll et al. JOURNAL OF ALZHEIMERS DISEASE
- Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates
- (2016) Mihirbaran Mandal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Linking Approach Using 19F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase
- (2016) John B. Jordan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors
- (2016) Yong-Jin Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease
- (2016) Jack D. Scott et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality
- (2016) Christopher R. Butler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
- (2016) Akanksha Kulshreshtha et al. NEUROLOGICAL SCIENCES
- BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease
- (2016) Soraia Barão et al. TRENDS IN NEUROSCIENCES
- Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
- (2016) Saoussen Ben Halima et al. Cell Reports
- BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
- (2016) Robert Vassar Journal of Sport and Health Science
- Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
- (2016) Riqiang Yan Translational Neurodegeneration
- Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease
- (2015) Jian Jeffrey Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Methyl-substitution of an iminohydantoin spiropiperidine β-secretase (BACE-1) inhibitor has a profound effect on its potency
- (2015) Melissa Egbertson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Alzheimer's Disease-Related Misfolded Proteins and Dysfunctional Organelles on Autophagy Menu
- (2015) Sónia C. Correia et al. DNA AND CELL BIOLOGY
- The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
- (2015) Cristina Carvalho et al. Expert Review of Neurotherapeutics
- Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design
- (2015) Christopher R. Butler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors
- (2015) Michael A. Brodney et al. JOURNAL OF MEDICINAL CHEMISTRY
- 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads
- (2015) Frederik J. R. Rombouts et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cerebrovascular and mitochondrial abnormalities in Alzheimer’s disease: a brief overview
- (2015) Cristina Carvalho et al. JOURNAL OF NEURAL TRANSMISSION
- The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central A Pharmacodynamic Responses in Mice, Dogs, and Humans
- (2015) P. C. May et al. JOURNAL OF NEUROSCIENCE
- An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities
- (2015) Yuan Cheng et al. ACS Medicinal Chemistry Letters
- The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
- (2015) Cristina Carvalho et al. Expert Review of Neurotherapeutics
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- The evolution of amidine-based brain penetrant BACE1 inhibitors
- (2014) Daniel Oehlrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
- (2014) Arun K. Ghosh et al. CHEMICAL SOCIETY REVIEWS
- Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System
- (2014) Allen A. Thomas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors
- (2014) Oleg Epstein et al. JOURNAL OF MEDICINAL CHEMISTRY
- 8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors
- (2014) Allen A. Thomas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)
- (2014) Thomas A. Dineen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the β secretase BACE1 for Alzheimer's disease therapy
- (2014) Riqiang Yan et al. LANCET NEUROLOGY
- Enhanced Amyloidogenic Processing of Amyloid Precursor Protein and Cell Death Under Prolonged Endoplasmic Reticulum Stress in Brain Endothelial Cells
- (2014) Ana I. Plácido et al. MOLECULAR NEUROBIOLOGY
- β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer’s disease
- (2014) Kelly Willemijn Menting et al. Frontiers in Aging Neuroscience
- BACE1 inhibitors: A head group scan on a series of amides
- (2013) Thomas J. Woltering et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease
- (2013) Hans Hilpert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species
- (2013) Kevin W. Hunt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease
- (2013) Jing Yuan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cyclopropyl-Fused 1,3-Thiazepines as BACE1 and BACE2 Inhibitors
- (2013) Benjamin Blass ACS Medicinal Chemistry Letters
- Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor
- (2012) Jared N. Cumming et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aminoimidazoles as BACE-1 inhibitors: The challenge to achieve in vivo brain efficacy
- (2012) Britt-Marie Swahn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain
- (2012) Ylva Gravenfors et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure- and Property-Based Design of Aminooxazoline Xanthenes as Selective, Orally Efficacious, and CNS Penetrable BACE Inhibitors for the Treatment of Alzheimer’s Disease
- (2012) Hongbing Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation
- (2012) Mihirbaran Mandal et al. JOURNAL OF MEDICINAL CHEMISTRY
- 5-Amino-oxazepine and 5-Amino-thiazepine Compounds as β-Secretase Antagonists and Methods of Use
- (2012) Benjamin Blass ACS Medicinal Chemistry Letters
- Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction
- (2012) Andrew W. Stamford et al. ACS Medicinal Chemistry Letters
- The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
- (2012) Bastian Dislich et al. Frontiers in Physiology
- New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: Exploring the S2′ region
- (2011) Michael S. Malamas et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)
- (2011) Yuan Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Developing β-secretase inhibitors for treatment of Alzheimer’s disease
- (2011) Arun K. Ghosh et al. JOURNAL OF NEUROCHEMISTRY
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Pyridinyl aminohydantoins as small molecule BACE1 inhibitors
- (2010) Ping Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability
- (2010) Michael S. Malamas et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation∥(1)
- (2010) Zhaoning Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The secretases: enzymes with therapeutic potential in Alzheimer disease
- (2010) Bart De Strooper et al. Nature Reviews Neurology
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors
- (2009) Michael S. Malamas et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Aminoimidazoles as Potent and Selective Human β-Secretase (BACE1) Inhibitors
- (2009) Michael S. Malamas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of 5,5′-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors
- (2009) Michael S. Malamas et al. JOURNAL OF MEDICINAL CHEMISTRY
- ER stress is involved in Aβ‐induced GSK‐3β activation and tau phosphorylation
- (2008) Rosa Resende et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More